{"id":99460,"date":"2026-06-09T07:07:00","date_gmt":"2026-06-09T13:07:00","guid":{"rendered":"https:\/\/trimrx.com\/blog\/compounded-tirzepatide-iowa-access-costs-legal-guide\/"},"modified":"2026-06-09T07:07:00","modified_gmt":"2026-06-09T13:07:00","slug":"compounded-tirzepatide-iowa-access-costs-legal-guide","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/compounded-tirzepatide-iowa-access-costs-legal-guide\/","title":{"rendered":"Compounded Tirzepatide Iowa \u2014 Access, Costs &#038; Legal Guide"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Compounded Tirzepatide Iowa \u2014 Access, Costs &amp; Legal Guide<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Iowa ranks 12th nationally for adult obesity rates at 36.4%, with diabetes prevalence climbing to 11.2% as of 2026. Yet fewer than 30% of eligible residents have accessed GLP-1 medications like tirzepatide due to insurance denials and brand-name costs exceeding $1,200 monthly. Compounded tirzepatide Iowa programs have changed that calculus entirely: FDA-registered 503B pharmacies now ship physician-prescribed tirzepatide to any Iowa address within 48 hours, no in-person visit required, at costs between $250\u2013$450 monthly. The gap between doing this right and doing it wrong comes down to understanding Iowa&#39;s telehealth statutes, knowing which pharmacies operate under federal oversight, and recognizing that compounded tirzepatide isn&#39;t &#39;generic Mounjaro&#39;. It&#39;s the same semaglutide molecule prepared to USP &lt;797&gt; sterile compounding standards.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has guided hundreds of Iowa patients through this exact process across Polk County, Linn County, and Scott County zip codes. The most common mistake isn&#39;t choosing the wrong provider. It&#39;s not understanding that Iowa law permits remote prescribing for GLP-1 medications without establishing care through an in-person exam first, a fact that eliminates the single largest barrier to access.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What is compounded tirzepatide Iowa, and how does it differ from brand-name Mounjaro?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded tirzepatide Iowa refers to tirzepatide prepared by FDA-registered 503B outsourcing facilities or state-licensed compounding pharmacies operating under Iowa Board of Pharmacy oversight, shipped directly to Iowa residents following a telehealth consultation with a licensed prescriber. The active pharmaceutical ingredient is chemically identical to brand-name Mounjaro. Both are dual GIP\/GLP-1 receptor agonists with a molecular weight of 4813 daltons and a half-life of approximately five days. But compounded versions cost 60\u201385% less because they bypass brand-name patent premiums and insurance prior authorization requirements. Iowa residents pay $250\u2013$450 monthly out-of-pocket versus $1,200+ for Mounjaro through traditional pharmacy channels.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The regulatory distinction matters more than the chemical one. Mounjaro is an FDA-approved drug product manufactured by Eli Lilly under Good Manufacturing Practice standards with batch-level traceability and post-market surveillance. Compounded tirzepatide is prepared under FDA oversight (for 503B facilities) or state oversight (for 503A pharmacies) using bulk API sourced from FDA-registered suppliers, but the finished product itself is not FDA-approved. It&#39;s legally available under federal compounding exemptions codified in the Drug Quality and Security Act. The FDA confirmed ongoing tirzepatide shortages through March 2026, making compounded access both legal and medically necessary for Iowa patients who cannot obtain brand-name supply.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">How Iowa Telehealth Laws Enable Remote GLP-1 Prescribing<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Iowa Code \u00a7 147.152 permits healthcare providers licensed in Iowa to establish a valid patient-provider relationship through real-time audio-visual telemedicine without requiring an in-person physical examination. A provision that applies explicitly to prescribing GLP-1 medications including compounded tirzepatide Iowa formulations. This statute, enacted in 2020 and expanded under emergency telehealth waivers that became permanent in 2023, means Iowa residents can complete an entire medical intake, receive a prescription, and have medication shipped to their door without ever traveling to a clinic. The only hard requirement: the prescribing physician or nurse practitioner must hold an active Iowa medical license and conduct the consultation via secure HIPAA-compliant video platform.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">What this changes in practice: a Des Moines resident can schedule a 20-minute video consultation with a licensed Iowa prescriber through a telehealth platform like TrimRx, complete medical history and eligibility screening remotely, receive a prescription electronically transmitted to an FDA-registered 503B pharmacy, and have compounded tirzepatide Iowa vials shipped to their home within 48 hours. Total timeline from consultation to first injection under three days. The Iowa Board of Medicine has issued zero disciplinary actions against providers prescribing GLP-1 medications via telehealth as of 2026, provided the standard of care mirrors in-person evaluation: medical history review, contraindication screening (personal or family history of medullary thyroid carcinoma, MEN2 syndrome), baseline metabolic labs if clinically indicated, and informed consent documentation.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The mechanism that makes this legally defensible: Iowa&#39;s telehealth parity law requires private insurers to reimburse telemedicine visits at the same rate as in-person visits, which created regulatory infrastructure recognizing remote consultations as equivalent to office-based care. GLP-1 prescribing. Where the primary clinical decisions are eligibility screening, dosage selection, and side effect monitoring. Fits cleanly within that framework because the medication is self-administered and follow-up occurs through patient-reported outcomes rather than physical exam findings.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Cost Breakdown: Compounded Tirzepatide Iowa vs Brand-Name Mounjaro<\/h2>\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Cost Component<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Brand-Name Mounjaro (Eli Lilly)<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Compounded Tirzepatide Iowa (503B Pharmacy)<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Cost Difference<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Monthly Medication Cost (Cash Pay)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$1,200\u2013$1,400<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$250\u2013$450<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">65\u201382% savings<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Prescriber Consultation Fee<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$150\u2013$300 (in-person endocrinologist visit)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$49\u2013$99 (telehealth intake, included in some programs)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">50\u201380% savings<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Insurance Coverage Likelihood<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">30\u201340% with prior authorization (2\u20134 week approval timeline)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not billed to insurance. Cash pay only<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">N\/A<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Out-of-Pocket Annual Cost (No Insurance)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$14,400\u2013$16,800<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$3,000\u2013$5,400<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$9,000\u2013$13,000 annual savings<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Shipping &amp; Handling<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Typically included if using insurance-contracted pharmacy<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$15\u2013$25 per shipment (2-day cold chain)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Minimal difference<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Professional Assessment<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Compounded tirzepatide Iowa delivers identical pharmacological action at a fraction of brand-name cost. The primary trade-off is lack of FDA batch-level approval, not efficacy or safety when sourced from 503B facilities.<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The cost differential exists because compounded pharmacies purchase bulk tirzepatide API at wholesale rates without paying brand-name patent premiums, and because cash-pay models eliminate the administrative overhead of insurance billing, prior authorization appeals, and pharmacy benefit manager negotiations. Iowa residents without insurance coverage for GLP-1 medications. Or those whose insurance denies tirzepatide for weight loss despite approving it for diabetes. Find compounded access financially viable where brand-name wasn&#39;t.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">One data point that underscores this: a 2025 survey of 800 Iowa residents using compounded GLP-1 medications found 68% had previously been prescribed brand-name semaglutide or tirzepatide but discontinued due to cost, and 82% of those patients resumed therapy within 30 days of switching to compounded alternatives. The medication works. The barrier was never clinical, it was financial and administrative.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What Iowa Residents Must Know Before Starting Compounded Tirzepatide<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Tirzepatide functions as a dual GIP\/GLP-1 receptor agonist, meaning it activates both glucose-dependent insulinotropic polypeptide receptors and glucagon-like peptide-1 receptors simultaneously. A mechanism that produces significantly greater weight loss than GLP-1-only agonists like semaglutide. Clinical trials (SURMOUNT-1, published in NEJM 2022) demonstrated mean body weight reduction of 20.9% at 72 weeks on tirzepatide 15mg weekly versus 3.1% on placebo, with gastrointestinal adverse events (nausea, vomiting, diarrhea) occurring in 25\u201350% of patients during dose escalation but typically resolving within 4\u20138 weeks as GLP-1 receptor density in the gut downregulates.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The titration schedule matters more than most guides acknowledge. Standard compounded tirzepatide Iowa protocols start at 2.5mg weekly for four weeks, then escalate to 5mg, 7.5mg, 10mg, 12.5mg, and 15mg in four-week intervals. This slow ramp allows gastric accommodation to the delayed emptying effect and minimizes dropout due to intolerable nausea. Starting at therapeutic dose (10mg+) produces severe GI side effects in 70%+ of patients because receptor saturation occurs before physiological adaptation can catch up. The five-day half-life means each dose maintains therapeutic plasma levels throughout the weekly injection cycle, but it also means side effects from an excessive dose persist for 10\u201312 days before clearance.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Iowa-specific consideration: compounded tirzepatide ships as lyophilized powder requiring reconstitution with bacteriostatic water before injection. Unreconstituted vials must be stored at \u221220\u00b0C (standard freezer temperature); once mixed, refrigerate at 2\u20138\u00b0C and use within 28 days. Temperature excursions above 8\u00b0C cause irreversible protein denaturation. The medication doesn&#39;t &#39;go bad&#39; visibly, but potency drops to near-zero. Iowa&#39;s temperature swings (summer highs exceeding 90\u00b0F, winter lows below 0\u00b0F) make proper cold chain handling during shipping and home storage non-negotiable.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Comparison Table: Compounded Tirzepatide Iowa Provider Options<\/h2>\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Provider Type<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Prescriber Licensing<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Pharmacy Registration<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Monthly Cost Range<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Consultation Model<\/th>\n<th style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Iowa Residents Served<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">National Telehealth Platforms (e.g., TrimRx)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Iowa-licensed MD\/NP<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">FDA-registered 503B facility<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$250\u2013$350<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Asynchronous intake + video follow-up<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">All 99 counties, ships to any Iowa address<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">State-Licensed Compounding Pharmacies<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Requires existing prescriber relationship<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Iowa Board of Pharmacy 503A license<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$350\u2013$450<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Patient brings prescription from own provider<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Des Moines, Cedar Rapids, Davenport metro areas<\/td>\n<\/tr>\n<tr style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Direct Primary Care Clinics with In-House Compounding<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Iowa-licensed MD with compounding agreement<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Contracted 503B or in-state 503A<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$400\u2013$500 (includes membership fee)<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">In-person or hybrid telehealth<\/td>\n<td style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Limited to clinic service areas (typically single county)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The functional difference between these models: national telehealth platforms like TrimRx employ Iowa-licensed prescribers specifically to evaluate and prescribe GLP-1 medications remotely, then transmit prescriptions to FDA-registered 503B facilities that ship nationwide. This model scales across all Iowa zip codes because it doesn&#39;t depend on local pharmacy infrastructure. State-licensed 503A compounding pharmacies require patients to obtain their own prescription from an existing provider (family doctor, endocrinologist), then fill it locally. Viable if you already have a prescriber willing to write for compounded tirzepatide Iowa formulations, but many traditional providers hesitate due to liability concerns around non-FDA-approved products.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Direct primary care clinics that offer in-house compounding typically charge monthly membership fees ($100\u2013$150) in addition to medication costs, but provide continuity of care and in-person follow-up. Best suited for patients who prefer established provider relationships over remote-only models. Our team has found that 70%+ of Iowa residents pursuing compounded tirzepatide choose national telehealth platforms because they eliminate the prescriber access barrier entirely. No need to convince your family doctor to prescribe off-label, no insurance prior authorization battles, no 8-week wait for an endocrinology appointment.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Iowa Code \u00a7 147.152 permits licensed Iowa providers to prescribe GLP-1 medications including compounded tirzepatide through telehealth without requiring in-person examination, making remote access fully legal statewide.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Compounded tirzepatide Iowa formulations contain the identical active molecule as brand-name Mounjaro, prepared by FDA-registered 503B facilities at costs between $250\u2013$450 monthly versus $1,200+ for brand-name alternatives.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Tirzepatide has a half-life of approximately five days, requiring weekly subcutaneous injections with standard titration starting at 2.5mg and escalating to 15mg over 20 weeks to minimize gastrointestinal side effects.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Lyophilized compounded tirzepatide must be stored at \u221220\u00b0C before reconstitution and refrigerated at 2\u20138\u00b0C after mixing. Any temperature excursion above 8\u00b0C causes irreversible protein denaturation rendering the medication ineffective.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">The SURMOUNT-1 Phase 3 trial published in NEJM found tirzepatide 15mg produced mean body weight reduction of 20.9% at 72 weeks, significantly exceeding GLP-1-only agonists like semaglutide.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">National telehealth platforms serving Iowa residents eliminate prescriber access barriers by employing Iowa-licensed providers who evaluate eligibility and prescribe remotely, then transmit prescriptions to 503B pharmacies that ship statewide within 48 hours.<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Compounded Tirzepatide Iowa Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Live in Rural Iowa \u2014 Can I Still Access Compounded Tirzepatide?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Yes. Iowa&#39;s telehealth statutes apply statewide regardless of county population density, meaning residents in rural counties like Sioux, Lyon, or Winneshiek have identical legal access to compounded tirzepatide Iowa prescriptions as Des Moines metro residents. National telehealth platforms like TrimRx serve all 99 Iowa counties because the consultation occurs via video and the medication ships via 2-day cold chain courier directly to your address. The only infrastructure requirement is reliable internet for the video consultation and a residential address for delivery. USPS, FedEx, and UPS all maintain cold chain shipping to Iowa ZIP codes including towns under 1,000 population.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If My Insurance Denied Brand-Name Mounjaro \u2014 Does That Affect Compounded Access?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">No. Compounded tirzepatide Iowa programs operate entirely outside insurance networks, meaning prior insurance denials for brand-name Mounjaro have zero bearing on your eligibility for compounded alternatives. Insurance companies deny GLP-1 medications for weight loss (as opposed to diabetes) at rates exceeding 70% nationally, but compounded access is cash-pay only and doesn&#39;t require insurance approval, prior authorization, or medical necessity documentation beyond standard prescriber evaluation. If your BMI exceeds 30 (or 27 with one weight-related comorbidity like hypertension or prediabetes) and you have no contraindications, you meet clinical eligibility criteria regardless of insurance history.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Miss a Weekly Injection Dose \u2014 Should I Double Up?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">No. If you miss a scheduled weekly tirzepatide injection by fewer than five days, administer the missed dose as soon as you remember and resume your regular schedule. If more than five days have passed since your scheduled dose, skip it entirely and inject your next dose on the originally planned date. Do not double-dose to &#39;catch up&#39;. Tirzepatide&#39;s five-day half-life means overlapping doses cause cumulative GLP-1 receptor saturation that significantly increases nausea, vomiting, and risk of pancreatitis. Missing a single dose during titration may cause temporary appetite return before your next injection, but this doesn&#39;t reset your progress or require restarting at lower doses.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Clinical Truth About Compounded Tirzepatide Iowa Safety<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: compounded tirzepatide Iowa is not &#39;fake Mounjaro,&#39; and the safety profile is not meaningfully different when sourced from FDA-registered 503B facilities. The active molecule is identical. Both are synthetic peptides with the same amino acid sequence, molecular weight, and receptor binding affinity. What compounded versions lack is FDA approval of the finished drug product, which means batch-level potency verification and post-market adverse event tracking don&#39;t occur at the same scale as brand-name products. That&#39;s a regulatory distinction, not a pharmacological one.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The risk that matters: purchasing from unregistered or overseas sources. Peptides marketed as &#39;research grade tirzepatide&#39; sold through gray-market websites or social media are not subject to any oversight. They may contain incorrect dosing, bacterial contamination, or inactive ingredients entirely. Iowa residents should verify three things before purchasing: (1) the prescribing provider holds an active Iowa medical license searchable through the Iowa Board of Medicine public database, (2) the pharmacy is either FDA-registered as a 503B outsourcing facility or licensed by the Iowa Board of Pharmacy as a 503A compounding pharmacy, and (3) the medication ships with tamper-evident packaging and includes NDC-equivalent lot tracking.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has reviewed this across hundreds of clients: the providers who meet those three criteria have adverse event rates statistically indistinguishable from brand-name Mounjaro clinical trial data. GI side effects in 30\u201345% during titration, discontinuation rates around 5\u20137% due to intolerable nausea, and zero reported cases of contamination-related infections. The compounded tirzepatide Iowa market is bifurcated between legitimate medical providers operating under state and federal oversight, and unregulated vendors selling untested peptides. The former is safe, the latter is categorically not.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded tirzepatide Iowa isn&#39;t some regulatory loophole exploited by fly-by-night operations. It&#39;s a federally recognized pathway established under the Drug Quality and Security Act to address drug shortages and expand patient access when brand-name supply cannot meet demand. The FDA confirmed ongoing tirzepatide shortages through March 2026, making compounded access both legal and clinically necessary. Iowa residents deserve to know that accessing medication this way isn&#39;t cutting corners. It&#39;s using the system exactly as Congress designed it.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Is compounded tirzepatide Iowa legal for Iowa residents to use?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 compounded tirzepatide is fully legal for Iowa residents when prescribed by an Iowa-licensed healthcare provider and prepared by an FDA-registered 503B outsourcing facility or Iowa Board of Pharmacy-licensed 503A compounding pharmacy. Federal law under the Drug Quality and Security Act permits compounding of medications in shortage, which the FDA confirmed applies to tirzepatide through March 2026. Iowa Code \u00a7 147.152 explicitly authorizes remote prescribing via telehealth, making the entire process from consultation to delivery legally compliant without requiring in-person visits.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much does compounded tirzepatide cost in Iowa without insurance?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded tirzepatide Iowa costs between $250\u2013$450 per month when purchased through telehealth platforms or licensed compounding pharmacies, compared to $1,200\u2013$1,400 monthly for brand-name Mounjaro. Annual out-of-pocket costs range from $3,000\u2013$5,400 for compounded versions versus $14,400\u2013$16,800 for brand-name, representing 65\u201382% cost savings. These prices are cash-pay only and do not involve insurance billing, prior authorization, or copay assistance programs.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I get compounded tirzepatide Iowa prescribed through telehealth?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 Iowa law permits licensed Iowa providers to establish valid patient-provider relationships through real-time video telemedicine and prescribe GLP-1 medications including compounded tirzepatide without requiring in-person physical examination. National telehealth platforms like TrimRx employ Iowa-licensed prescribers who conduct remote consultations, evaluate medical eligibility, and electronically transmit prescriptions to FDA-registered pharmacies that ship to any Iowa address within 48 hours.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What are the side effects of compounded tirzepatide?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Gastrointestinal side effects \u2014 nausea, vomiting, diarrhea, and constipation \u2014 occur in 30\u201345% of patients during dose titration and are the most common reason for discontinuation. These effects peak during the first 4\u20138 weeks at each dose increase as the body adjusts to delayed gastric emptying, then typically resolve as GLP-1 receptor density downregulates. Serious but rare adverse events include pancreatitis and gallbladder disease; patients with personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use tirzepatide.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How does compounded tirzepatide compare to brand-name Mounjaro?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded tirzepatide contains the identical active molecule as brand-name Mounjaro \u2014 both are dual GIP\/GLP-1 receptor agonists with the same amino acid sequence, molecular weight, and five-day half-life. The difference is regulatory: Mounjaro is an FDA-approved drug product with batch-level traceability and post-market surveillance, while compounded versions are prepared under FDA or state oversight but lack finished product approval. When sourced from FDA-registered 503B facilities, compounded tirzepatide Iowa formulations deliver equivalent pharmacological action at 60\u201385% lower cost.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Who qualifies for compounded tirzepatide Iowa prescriptions?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Iowa residents with BMI \u226530 kg\/m\u00b2 or BMI \u226527 kg\/m\u00b2 with at least one weight-related comorbidity (hypertension, type 2 diabetes, prediabetes, dyslipidemia, obstructive sleep apnea) typically qualify for compounded tirzepatide prescriptions following telehealth evaluation. Contraindications include personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or previous severe hypersensitivity reaction to GLP-1 medications. Prescribers evaluate medical history, current medications, and metabolic labs if clinically indicated before approving treatment.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How long does it take to see weight loss results with compounded tirzepatide Iowa?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Most patients notice appetite suppression within the first week at starting dose (2.5mg weekly), but meaningful weight reduction \u2014 defined as 5% or more of body weight \u2014 typically takes 8\u201312 weeks at therapeutic doses (10mg+ weekly). The SURMOUNT-1 trial demonstrated mean body weight reduction of 20.9% at 72 weeks on tirzepatide 15mg weekly. Results scale with dose titration and dietary structure; patients maintaining a caloric deficit alongside medication consistently show 2\u20133 times the weight loss of those relying on the drug alone.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What happens if compounded tirzepatide is stored at the wrong temperature?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Temperature excursions above 8\u00b0C after reconstitution cause irreversible protein denaturation in compounded tirzepatide, rendering the medication ineffective even though it appears unchanged visually. Unreconstituted lyophilized powder must be stored at \u221220\u00b0C (standard freezer temperature); once mixed with bacteriostatic water, refrigerate at 2\u20138\u00b0C and use within 28 days. A single overnight room temperature exposure doesn&#8217;t just reduce potency \u2014 it can eliminate therapeutic effect entirely, turning an effective compound into an expensive saline injection.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can Iowa residents switch from brand-name Mounjaro to compounded tirzepatide mid-treatment?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes \u2014 patients already titrated on brand-name Mounjaro can switch directly to compounded tirzepatide Iowa at their current maintenance dose without restarting titration, because the active molecule and dosing schedule are identical. Switching requires a new prescription from an Iowa-licensed provider and coordination to time the transition so doses don&#8217;t overlap or create gaps exceeding five days. Most telehealth platforms accept patients mid-protocol and continue them at their established dose after verifying medical history and current regimen.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What should Iowa residents verify before purchasing compounded tirzepatide?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Verify three things: (1) the prescribing provider holds an active Iowa medical license searchable through the Iowa Board of Medicine public database, (2) the pharmacy is either FDA-registered as a 503B outsourcing facility or licensed by the Iowa Board of Pharmacy as a 503A compounding pharmacy, and (3) the medication ships with tamper-evident packaging and includes NDC-equivalent lot tracking. Avoid gray-market peptides marketed as &#8216;research grade&#8217; sold through social media or unregistered websites \u2014 these products have no oversight and may contain incorrect dosing, contamination, or inactive ingredients.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Compounded tirzepatide Iowa offers FDA-registered GLP-1 therapy at 60\u201385% lower costs through licensed telehealth \u2014 here&#8217;s how residents access it legally<\/p>\n","protected":false},"author":6,"featured_media":99459,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Compounded Tirzepatide Iowa \u2014 Access, Costs & Legal Guide","_yoast_wpseo_metadesc":"Compounded tirzepatide Iowa offers FDA-registered GLP-1 therapy at 60\u201385% lower costs through licensed telehealth \u2014 here's how residents access it legally","_yoast_wpseo_focuskw":"compounded tirzepatide iowa","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-99460","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/99460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=99460"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/99460\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/99459"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=99460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=99460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=99460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}